Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

E. Olsen, M. Duvic, A. Frankel, Y. Kim, A. Martin, E. Vonderheid, B. Jegasothy, G. Wood, M. Gordon, P. Heald, A. Oseroff, L. Pinter-Brown, G. Bowen, T. Kuzel, D. Fivenson, F. Foss, M. Glode, A. Molina, E. Knobler, S. StewartK. Cooper, S. Stevens, F. Craig, J. Reuben, P. Bacha, J. Nichols

Research output: Contribution to journalArticlepeer-review

557 Scopus citations

Fingerprint

Dive into the research topics of 'Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences